Completion of acquisition of Amphora Health

Voyager, the health and wellness group formulating, manufacturing and supplying high-quality Cannabidiol (CBD), hemp seed oil and hemp-related products, is pleased to announce that, further to the announcement of 30 January 2024, it has completed its acquisition of Amphora Health Ltd ("Amphora"), owner of the Amphora and Infused Amphora brands.

Over the coming months, Voyager expects to commence manufacturing of Amphora branded products, primarily its range of CBD oils and vapour products. The CBD oils are validated on the FSA's novel foods list and vapour products represents a new product listing for Voyager. As previously announced in respect of forthcoming changes in UK legislation, Amphora vapour products are not disposable but are currently sold in cartridges for use with a rechargeable battery. Furthermore Voyager intends to supply the formula as an e-liquid for customers to refill their preferred vapour products themselves.

Amphora's current inventories which are estimated by Voyager to have a value in excess of £50,000 (at cost) will be sold through the Company's current sales channels, including its three own stores and its website.

The consideration payable for Amphora has been satisfied through the issue of 416,666 new ordinary shares of £0.01 each in Voyager at a price of 12 pence per share (approximately £50,000) in aggregate to Amphora's shareholders. In addition, a further 416,666 new ordinary shares at a price of 12 pence per share may be issued in the event, inter alia, that sales of Amphora or Infused Amphora branded products exceed £100,000 over the 24 month period from completion.

Admission

Application has been made for 416,666 new ordinary shares to be admitted to trading on the Aquis Stock Exchange Growth Market ("Admission"). Admission is expected to occur at 8:00 am on or around 13 March 2023. The new ordinary shares will rank pari passu with the existing ordinary shares.

Total Voting Rights

Following Admission, the Company's enlarged share capital will comprise 14,402,910 ordinary shares ordinary shares of 1 pence each. Therefore, the total number of voting rights in the Company will be 14,402,910. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the Company, or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

voyagerCann:

Amphora: